CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.44−0.12 (-0.16%)
Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –
CareDx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
CareDx's shares outstanding was 55M at Sep 30, 2026. For fiscal 2025 it was 53M, down 5.9% from the year before. Over ten years it grew 16.2% a year on average. The highest annual figure on record is 57M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 53M | -5.9% |
| FY2024 | Dec 31, 2024 | 57M | +5.3% |
| FY2023 | Dec 31, 2023 | 54M | +0.8% |
| FY2022 | Dec 31, 2022 | 53M | +2.1% |
| FY2021 | Dec 31, 2021 | 52M | +12.4% |
| FY2020 | Dec 31, 2020 | 46M | +10.3% |
| FY2019 | Dec 31, 2019 | 42M | +18.3% |
| FY2018 | Dec 31, 2018 | 36M | +52.7% |
| FY2017 | Dec 31, 2017 | 23M | +41.4% |
| FY2016 | Dec 31, 2016 | 16M | +39.1% |
| FY2015 | Dec 31, 2015 | 12M | +27.8% |
| FY2014 | Dec 31, 2014 | 9M | +818.4% |
| FY2013 | Dec 31, 2013 | 1M | +0.2% |
| FY2012 | Dec 31, 2012 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 55M | +2.3% |
| Q2 FY2026 | Jun 30, 2026 | 53M | -1.6% |
| Q1 FY2026 | Mar 31, 2026 | 53M | -3.9% |
| Q4 FY2025 | Dec 31, 2025 | 51M | -26.7% |
| Q3 FY2025 | Sep 30, 2025 | 54M | +1.6% |
| Q2 FY2025 | Jun 30, 2025 | 54M | +4.0% |
| Q1 FY2025 | Mar 31, 2025 | 55M | +6.9% |
| Q4 FY2024 | Dec 31, 2024 | 70M | +30.5% |
| Q3 FY2024 | Sep 30, 2024 | 53M | -2.4% |
| Q2 FY2024 | Jun 30, 2024 | 52M | -3.1% |
| Q1 FY2024 | Mar 31, 2024 | 52M | -3.6% |
| Q4 FY2023 | Dec 31, 2023 | 53M | -0.3% |
| Q3 FY2023 | Sep 30, 2023 | 54M | +1.3% |
| Q2 FY2023 | Jun 30, 2023 | 54M | +1.1% |
| Q1 FY2023 | Mar 31, 2023 | 54M | +1.2% |
| Q4 FY2022 | Dec 31, 2022 | 54M | +1.3% |
| Q3 FY2022 | Sep 30, 2022 | 53M | +1.5% |
| Q2 FY2022 | Jun 30, 2022 | 53M | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | 53M | +3.6% |
| Q4 FY2021 | Dec 31, 2021 | 53M | +7.1% |
| Q3 FY2021 | Sep 30, 2021 | 53M | +7.5% |
| Q2 FY2021 | Jun 30, 2021 | 52M | +16.8% |
| Q1 FY2021 | Mar 31, 2021 | 51M | +19.5% |
| Q4 FY2020 | Dec 31, 2020 | 49M | +16.2% |
| Q3 FY2020 | Sep 30, 2020 | 49M | +15.6% |
| Q2 FY2020 | Jun 30, 2020 | 45M | +6.1% |
| Q1 FY2020 | Mar 31, 2020 | 43M | +2.9% |
| Q4 FY2019 | Dec 31, 2019 | 42M | +5.9% |
| Q3 FY2019 | Sep 30, 2019 | 42M | +14.1% |
| Q2 FY2019 | Jun 30, 2019 | 42M | +18.5% |
| Q1 FY2019 | Mar 31, 2019 | 42M | +40.5% |
| Q4 FY2018 | Dec 31, 2018 | 40M | +43.3% |
| Q3 FY2018 | Sep 30, 2018 | 37M | +64.9% |
| Q2 FY2018 | Jun 30, 2018 | 36M | +66.0% |
| Q1 FY2018 | Mar 31, 2018 | 30M | +38.8% |
| Q4 FY2017 | Dec 31, 2017 | 28M | +31.6% |
| Q3 FY2017 | Sep 30, 2017 | 23M | – |
| Q2 FY2017 | Jun 30, 2017 | 21M | – |
| Q1 FY2017 | Mar 31, 2017 | 21M | – |
| Q4 FY2016 | Dec 31, 2016 | 21M | – |
See a number that looks wrong?